Home >
Baby >
Pharmacoeconomic and value demonstration
 |
Today pharmacoeconomics is often a primary driver of a product's
commercial success. The pre-launch heritage and pedigree
of PHASE II has resulted in an in-depth understanding to
ensure post-launch success. PHASE II can help you demonstrate
the burden of illness in your target therapy area and identify
the cost-saving factors. Our pharmacoeconomic associates
can help you evaluate your health economics strategy and
develop sub-protocols to collect the right cost data alongside
the clinical protocols that are aligned to the phase III
studies. We can assist with analysis and synthesis, populate
a model and support the arguments on cost-effectiveness.
The results are written up for publication and, by working
with clinical KOLs and health economics experts, we can
organize and implement a presentation strategy to publicize
the value demonstration story for your product.
Pharmacoeconomics for effective
value demonstration
(Click
to view)
|
|
|
